cohortId,targetId,targetName,strataId,strataName,cohortType
101,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,0,All,Target
102,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,0,All,Target
103,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,0,All,Target
104,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,0,All,Target
105,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,0,All,Target
106,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,0,All,Target
107,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,0,All,Target
108,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,0,All,Target
109,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,0,All,Target
110,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,0,All,Target
111,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,0,All,Target
112,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,0,All,Target
113,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,0,All,Target
114,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,0,All,Target
115,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,0,All,Target
116,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,0,All,Target
117,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,0,All,Target
118,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,0,All,Target
101003012,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
102003012,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
103003012,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
104003012,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
105003012,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
106003012,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
107003012,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
108003012,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
109003012,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
110003012,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
111003012,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
112003012,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
113003012,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
114003012,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
115003012,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
116003012,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
117003012,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
118003012,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,301,without [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwoS
101003022,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
102003022,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
103003022,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
104003022,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
105003022,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
106003022,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
107003022,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
108003022,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
109003022,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
110003022,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
111003022,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
112003022,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
113003022,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
114003022,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
115003022,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
116003022,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
117003022,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
118003022,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,302,without [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwoS
101003032,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
102003032,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
103003032,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
104003032,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
105003032,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
106003032,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
107003032,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
108003032,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
109003032,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
110003032,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
111003032,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
112003032,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
113003032,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
114003032,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
115003032,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
116003032,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
117003032,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
118003032,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,303,without [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwoS
101003042,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
102003042,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
103003042,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
104003042,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
105003042,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
106003042,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
107003042,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
108003042,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
109003042,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
110003042,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
111003042,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
112003042,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
113003042,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
114003042,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
115003042,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
116003042,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
117003042,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
118003042,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,304,without [PIONEER 2.0] Prevalent obesity FINAL,TwoS
101003052,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
102003052,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
103003052,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
104003052,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
105003052,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
106003052,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
107003052,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
108003052,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
109003052,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
110003052,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
111003052,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
112003052,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
113003052,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
114003052,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
115003052,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
116003052,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
117003052,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
118003052,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,305,without [PIONEER 2.0] Prevalent hypertension FINAL,TwoS
101003062,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
102003062,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
103003062,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
104003062,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
105003062,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
106003062,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
107003062,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
108003062,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
109003062,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
110003062,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
111003062,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
112003062,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
113003062,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
114003062,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
115003062,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
116003062,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
117003062,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
118003062,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,306,without [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwoS
101003072,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
102003072,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
103003072,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
104003072,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
105003072,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
106003072,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
107003072,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
108003072,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
109003072,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
110003072,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
111003072,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
112003072,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
113003072,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
114003072,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
115003072,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
116003072,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
117003072,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
118003072,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,307,without [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwoS
101003082,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
102003082,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
103003082,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
104003082,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
105003082,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
106003082,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
107003082,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
108003082,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
109003082,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
110003082,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
111003082,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
112003082,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
113003082,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
114003082,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
115003082,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
116003082,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
117003082,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
118003082,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,308,without [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwoS
101003092,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
102003092,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
103003092,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
104003092,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
105003092,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
106003092,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
107003092,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
108003092,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
109003092,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
110003092,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
111003092,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
112003092,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
113003092,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
114003092,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
115003092,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
116003092,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
117003092,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
118003092,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,309,without [PIONEER 2.0] Anxiety FINAL,TwoS
101003102,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
102003102,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
103003102,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
104003102,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
105003102,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
106003102,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
107003102,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
108003102,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
109003102,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
110003102,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
111003102,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
112003102,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
113003102,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
114003102,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
115003102,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
116003102,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
117003102,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
118003102,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,310,without [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwoS
101003112,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
102003112,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
103003112,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
104003112,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
105003112,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
106003112,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
107003112,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
108003112,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
109003112,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
110003112,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
111003112,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
112003112,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
113003112,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
114003112,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
115003112,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
116003112,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
117003112,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
118003112,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,311,without [PIONEER 2.0] Family History of PCa FINAL,TwoS
101003122,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
102003122,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
103003122,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
104003122,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
105003122,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
106003122,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
107003122,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
108003122,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
109003122,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
110003122,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
111003122,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
112003122,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
113003122,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
114003122,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
115003122,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
116003122,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
117003122,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
118003122,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,312,without [PIONEER 2.0] Physical Therapy FINAL,TwoS
101003132,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
102003132,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
103003132,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
104003132,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
105003132,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
106003132,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
107003132,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
108003132,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
109003132,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
110003132,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
111003132,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
112003132,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
113003132,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
114003132,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
115003132,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
116003132,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
117003132,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
118003132,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,313,without [PIONEER 2.0] Metastasis stage M1a FINAL,TwoS
101003142,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
102003142,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
103003142,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
104003142,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
105003142,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
106003142,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
107003142,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
108003142,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
109003142,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
110003142,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
111003142,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
112003142,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
113003142,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
114003142,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
115003142,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
116003142,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
117003142,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
118003142,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,314,without [PIONEER 2.0] Metastasis stage M1b FINAL,TwoS
101003152,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
102003152,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
103003152,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
104003152,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
105003152,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
106003152,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
107003152,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
108003152,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
109003152,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
110003152,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
111003152,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
112003152,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
113003152,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
114003152,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
115003152,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
116003152,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
117003152,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
118003152,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,315,without [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwoS
101003162,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
102003162,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
103003162,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
104003162,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
105003162,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
106003162,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
107003162,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
108003162,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
109003162,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
110003162,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
111003162,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
112003162,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
113003162,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
114003162,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
115003162,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
116003162,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
117003162,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
118003162,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,316,"without [PIONEER 2.0] N1, M0Mx, any T FINAL",TwoS
101003172,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
102003172,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
103003172,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
104003172,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
105003172,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
106003172,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
107003172,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
108003172,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
109003172,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
110003172,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
111003172,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
112003172,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
113003172,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
114003172,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
115003172,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
116003172,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
117003172,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
118003172,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,317,without [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwoS
101003182,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
102003182,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
103003182,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
104003182,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
105003182,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
106003182,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
107003182,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
108003182,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
109003182,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
110003182,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
111003182,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
112003182,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
113003182,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
114003182,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
115003182,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
116003182,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
117003182,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
118003182,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,318,without [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwoS
101003192,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
102003192,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
103003192,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
104003192,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
105003192,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
106003192,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
107003192,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
108003192,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
109003192,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
110003192,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
111003192,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
112003192,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
113003192,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
114003192,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
115003192,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
116003192,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
117003192,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
118003192,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,319,without [PIONEER 2.0] CT scan of whole body around Dx,TwoS
101003202,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
102003202,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
103003202,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
104003202,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
105003202,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
106003202,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
107003202,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
108003202,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
109003202,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
110003202,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
111003202,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
112003202,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
113003202,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
114003202,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
115003202,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
116003202,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
117003202,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
118003202,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,320,without [PIONEER 2.0] CT scan of whole body around metastasis,TwoS
101003212,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
102003212,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
103003212,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
104003212,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
105003212,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
106003212,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
107003212,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
108003212,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
109003212,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
110003212,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
111003212,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
112003212,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
113003212,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
114003212,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
115003212,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
116003212,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
117003212,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
118003212,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,321,without [PIONEER 2.0] PSA above 20 at Dx FINAL,TwoS
101003222,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
102003222,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
103003222,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
104003222,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
105003222,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
106003222,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
107003222,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
108003222,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
109003222,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
110003222,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
111003222,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
112003222,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
113003222,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
114003222,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
115003222,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
116003222,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
117003222,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
118003222,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,322,without [PIONEER 2.0] PSA below 10 at Dx FINAL,TwoS
101003232,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
102003232,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
103003232,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
104003232,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
105003232,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
106003232,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
107003232,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
108003232,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
109003232,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
110003232,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
111003232,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
112003232,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
113003232,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
114003232,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
115003232,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
116003232,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
117003232,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
118003232,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,323,without [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwoS
101003242,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
102003242,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
103003242,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
104003242,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
105003242,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
106003242,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
107003242,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
108003242,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
109003242,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
110003242,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
111003242,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
112003242,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
113003242,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
114003242,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
115003242,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
116003242,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
117003242,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
118003242,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,324,without [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwoS
101003252,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
102003252,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
103003252,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
104003252,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
105003252,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
106003252,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
107003252,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
108003252,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
109003252,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
110003252,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
111003252,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
112003252,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
113003252,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
114003252,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
115003252,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
116003252,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
117003252,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
118003252,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,325,without [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwoS
101003262,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
102003262,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
103003262,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
104003262,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
105003262,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
106003262,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
107003262,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
108003262,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
109003262,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
110003262,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
111003262,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
112003262,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
113003262,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
114003262,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
115003262,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
116003262,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
117003262,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
118003262,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,326,without [PIONEER V2.0] Earliest Gleason Grade 4,TwoS
101003272,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
102003272,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
103003272,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
104003272,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
105003272,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
106003272,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
107003272,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
108003272,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
109003272,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
110003272,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
111003272,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
112003272,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
113003272,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
114003272,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
115003272,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
116003272,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
117003272,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
118003272,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,327,without [PIONEER V2.0] Earliest Gleason Grade 5,TwoS
101003282,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,328,without [PIONEER S1] High-Risk,TwoS
102003282,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,328,without [PIONEER S1] High-Risk,TwoS
103003282,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,328,without [PIONEER S1] High-Risk,TwoS
104003282,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
105003282,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,328,without [PIONEER S1] High-Risk,TwoS
106003282,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
107003282,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
108003282,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
109003282,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
110003282,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
111003282,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,328,without [PIONEER S1] High-Risk,TwoS
112003282,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,328,without [PIONEER S1] High-Risk,TwoS
113003282,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,328,without [PIONEER S1] High-Risk,TwoS
114003282,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,328,without [PIONEER S1] High-Risk,TwoS
115003282,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
116003282,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
117003282,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
118003282,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,328,without [PIONEER S1] High-Risk,TwoS
101003292,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,329,without [PIONEER S2] Low-Risk,TwoS
102003292,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,329,without [PIONEER S2] Low-Risk,TwoS
103003292,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,329,without [PIONEER S2] Low-Risk,TwoS
104003292,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
105003292,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,329,without [PIONEER S2] Low-Risk,TwoS
106003292,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
107003292,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
108003292,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
109003292,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
110003292,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
111003292,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,329,without [PIONEER S2] Low-Risk,TwoS
112003292,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,329,without [PIONEER S2] Low-Risk,TwoS
113003292,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,329,without [PIONEER S2] Low-Risk,TwoS
114003292,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,329,without [PIONEER S2] Low-Risk,TwoS
115003292,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
116003292,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
117003292,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
118003292,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,329,without [PIONEER S2] Low-Risk,TwoS
101003302,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
102003302,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
103003302,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
104003302,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
105003302,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
106003302,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
107003302,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
108003302,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
109003302,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
110003302,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
111003302,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
112003302,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
113003302,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
114003302,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
115003302,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
116003302,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
117003302,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
118003302,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,330,without [PIONEER S3] Intermediate-Risk,TwoS
101003312,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
102003312,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
103003312,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
104003312,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
105003312,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
106003312,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
107003312,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
108003312,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
109003312,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
110003312,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
111003312,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
112003312,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
113003312,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
114003312,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
115003312,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
116003312,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
117003312,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
118003312,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,331,without [PIONEER 2.0] MRI of prostate FINAL,TwoS
101003322,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
102003322,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
103003322,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
104003322,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
105003322,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
106003322,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
107003322,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
108003322,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
109003322,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
110003322,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
111003322,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
112003322,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
113003322,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
114003322,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
115003322,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
116003322,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
117003322,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
118003322,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,332,without [PIONEER 2.0] Bone scan FINAL,TwoS
101003332,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
102003332,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
103003332,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
104003332,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
105003332,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
106003332,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
107003332,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
108003332,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
109003332,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
110003332,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
111003332,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
112003332,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
113003332,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
114003332,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
115003332,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
116003332,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
117003332,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
118003332,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,333,without [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwoS
101003342,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
102003342,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
103003342,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
104003342,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
105003342,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
106003342,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
107003342,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
108003342,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
109003342,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
110003342,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
111003342,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
112003342,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
113003342,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
114003342,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
115003342,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
116003342,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
117003342,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
118003342,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,334,without [PIONEER 2.0] PET-CT imaging FINAL,TwoS
101003352,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
102003352,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
103003352,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
104003352,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
105003352,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
106003352,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
107003352,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
108003352,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
109003352,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
110003352,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
111003352,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
112003352,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
113003352,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
114003352,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
115003352,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
116003352,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
117003352,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
118003352,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,335,without [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwoS
101003362,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
102003362,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
103003362,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
104003362,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
105003362,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
106003362,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
107003362,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
108003362,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
109003362,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
110003362,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
111003362,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
112003362,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
113003362,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
114003362,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
115003362,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
116003362,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
117003362,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
118003362,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,336,without [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwoS
101003372,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
102003372,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
103003372,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
104003372,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
105003372,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
106003372,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
107003372,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
108003372,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
109003372,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
110003372,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
111003372,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
112003372,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
113003372,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
114003372,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
115003372,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
116003372,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
117003372,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
118003372,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,337,without [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwoS
101003382,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
102003382,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
103003382,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
104003382,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
105003382,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
106003382,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
107003382,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
108003382,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
109003382,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
110003382,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
111003382,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
112003382,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
113003382,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
114003382,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
115003382,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
116003382,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
117003382,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
118003382,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,338,without [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwoS
101003392,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
102003392,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
103003392,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
104003392,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
105003392,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
106003392,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
107003392,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
108003392,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
109003392,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
110003392,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
111003392,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
112003392,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
113003392,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
114003392,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
115003392,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
116003392,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
117003392,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
118003392,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,339,without [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwoS
101003402,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
102003402,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
103003402,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
104003402,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
105003402,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
106003402,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
107003402,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
108003402,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
109003402,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
110003402,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
111003402,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
112003402,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
113003402,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
114003402,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
115003402,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
116003402,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
117003402,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
118003402,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,340,without [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwoS
101000011,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,1,with Age < 60,TwS
102000011,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,1,with Age < 60,TwS
103000011,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,1,with Age < 60,TwS
104000011,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,1,with Age < 60,TwS
105000011,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,1,with Age < 60,TwS
106000011,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,1,with Age < 60,TwS
107000011,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,1,with Age < 60,TwS
108000011,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,1,with Age < 60,TwS
109000011,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,1,with Age < 60,TwS
110000011,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,1,with Age < 60,TwS
111000011,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,1,with Age < 60,TwS
112000011,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,1,with Age < 60,TwS
113000011,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,1,with Age < 60,TwS
114000011,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,1,with Age < 60,TwS
115000011,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,1,with Age < 60,TwS
116000011,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,1,with Age < 60,TwS
117000011,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,1,with Age < 60,TwS
118000011,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,1,with Age < 60,TwS
101000021,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,2,with Age 60 - 69,TwS
102000021,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,2,with Age 60 - 69,TwS
103000021,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,2,with Age 60 - 69,TwS
104000021,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,2,with Age 60 - 69,TwS
105000021,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,2,with Age 60 - 69,TwS
106000021,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,2,with Age 60 - 69,TwS
107000021,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,2,with Age 60 - 69,TwS
108000021,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,2,with Age 60 - 69,TwS
109000021,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,2,with Age 60 - 69,TwS
110000021,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,2,with Age 60 - 69,TwS
111000021,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,2,with Age 60 - 69,TwS
112000021,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,2,with Age 60 - 69,TwS
113000021,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,2,with Age 60 - 69,TwS
114000021,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,2,with Age 60 - 69,TwS
115000021,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,2,with Age 60 - 69,TwS
116000021,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,2,with Age 60 - 69,TwS
117000021,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,2,with Age 60 - 69,TwS
118000021,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,2,with Age 60 - 69,TwS
101000031,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,3,with Age 70 - 79,TwS
102000031,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,3,with Age 70 - 79,TwS
103000031,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,3,with Age 70 - 79,TwS
104000031,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,3,with Age 70 - 79,TwS
105000031,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,3,with Age 70 - 79,TwS
106000031,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,3,with Age 70 - 79,TwS
107000031,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,3,with Age 70 - 79,TwS
108000031,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,3,with Age 70 - 79,TwS
109000031,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,3,with Age 70 - 79,TwS
110000031,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,3,with Age 70 - 79,TwS
111000031,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,3,with Age 70 - 79,TwS
112000031,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,3,with Age 70 - 79,TwS
113000031,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,3,with Age 70 - 79,TwS
114000031,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,3,with Age 70 - 79,TwS
115000031,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,3,with Age 70 - 79,TwS
116000031,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,3,with Age 70 - 79,TwS
117000031,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,3,with Age 70 - 79,TwS
118000031,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,3,with Age 70 - 79,TwS
101000041,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,4,with Age >= 80,TwS
102000041,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,4,with Age >= 80,TwS
103000041,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,4,with Age >= 80,TwS
104000041,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,4,with Age >= 80,TwS
105000041,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,4,with Age >= 80,TwS
106000041,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,4,with Age >= 80,TwS
107000041,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,4,with Age >= 80,TwS
108000041,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,4,with Age >= 80,TwS
109000041,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,4,with Age >= 80,TwS
110000041,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,4,with Age >= 80,TwS
111000041,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,4,with Age >= 80,TwS
112000041,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,4,with Age >= 80,TwS
113000041,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,4,with Age >= 80,TwS
114000041,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,4,with Age >= 80,TwS
115000041,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,4,with Age >= 80,TwS
116000041,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,4,with Age >= 80,TwS
117000041,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,4,with Age >= 80,TwS
118000041,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,4,with Age >= 80,TwS
101003011,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
102003011,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
103003011,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
104003011,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
105003011,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
106003011,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
107003011,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
108003011,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
109003011,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
110003011,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
111003011,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
112003011,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
113003011,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
114003011,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
115003011,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
116003011,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
117003011,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
118003011,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,301,with [PIONEER 2.0] Performance Status ECOG=0 at met Dx FINAL,TwS
101003021,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
102003021,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
103003021,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
104003021,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
105003021,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
106003021,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
107003021,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
108003021,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
109003021,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
110003021,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
111003021,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
112003021,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
113003021,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
114003021,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
115003021,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
116003021,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
117003021,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
118003021,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,302,with [PIONEER 2.0] Performance Status ECOG=1 at met Dx FINAL,TwS
101003031,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
102003031,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
103003031,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
104003031,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
105003031,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
106003031,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
107003031,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
108003031,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
109003031,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
110003031,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
111003031,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
112003031,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
113003031,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
114003031,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
115003031,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
116003031,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
117003031,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
118003031,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,303,with [PIONEER 2.0] Performance Status ECOG=2+ at met Dx FINAL,TwS
101003041,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
102003041,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
103003041,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
104003041,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
105003041,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
106003041,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
107003041,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
108003041,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
109003041,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
110003041,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
111003041,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
112003041,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
113003041,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
114003041,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
115003041,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
116003041,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
117003041,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
118003041,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,304,with [PIONEER 2.0] Prevalent obesity FINAL,TwS
101003051,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
102003051,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
103003051,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
104003051,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
105003051,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
106003051,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
107003051,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
108003051,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
109003051,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
110003051,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
111003051,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
112003051,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
113003051,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
114003051,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
115003051,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
116003051,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
117003051,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
118003051,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,305,with [PIONEER 2.0] Prevalent hypertension FINAL,TwS
101003061,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
102003061,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
103003061,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
104003061,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
105003061,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
106003061,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
107003061,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
108003061,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
109003061,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
110003061,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
111003061,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
112003061,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
113003061,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
114003061,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
115003061,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
116003061,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
117003061,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
118003061,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,306,with [PIONEER 2.0] Total Cardiovascular Disease Event FINAL,TwS
101003071,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
102003071,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
103003071,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
104003071,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
105003071,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
106003071,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
107003071,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
108003071,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
109003071,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
110003071,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
111003071,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
112003071,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
113003071,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
114003071,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
115003071,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
116003071,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
117003071,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
118003071,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,307,with [PIONEER 2.0] Prevalent Type 2 Diabetes Mellitus FINAL,TwS
101003081,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
102003081,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
103003081,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
104003081,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
105003081,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
106003081,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
107003081,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
108003081,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
109003081,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
110003081,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
111003081,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
112003081,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
113003081,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
114003081,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
115003081,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
116003081,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
117003081,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
118003081,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,308,with [PIONEER 2.0] Venous thromboembolic (pulmonary embolism and deep vein thrombosis) events FINAL,TwS
101003091,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
102003091,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
103003091,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
104003091,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
105003091,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
106003091,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
107003091,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
108003091,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
109003091,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
110003091,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
111003091,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
112003091,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
113003091,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
114003091,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
115003091,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
116003091,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
117003091,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
118003091,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,309,with [PIONEER 2.0] Anxiety FINAL,TwS
101003101,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
102003101,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
103003101,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
104003101,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
105003101,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
106003101,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
107003101,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
108003101,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
109003101,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
110003101,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
111003101,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
112003101,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
113003101,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
114003101,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
115003101,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
116003101,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
117003101,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
118003101,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,310,with [PIONEER 2.0] Prevalent Asthma or COPD FINAL,TwS
101003111,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
102003111,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
103003111,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
104003111,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
105003111,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
106003111,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
107003111,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
108003111,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
109003111,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
110003111,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
111003111,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
112003111,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
113003111,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
114003111,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
115003111,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
116003111,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
117003111,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
118003111,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,311,with [PIONEER 2.0] Family History of PCa FINAL,TwS
101003121,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
102003121,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
103003121,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
104003121,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
105003121,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
106003121,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
107003121,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
108003121,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
109003121,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
110003121,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
111003121,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
112003121,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
113003121,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
114003121,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
115003121,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
116003121,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
117003121,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
118003121,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,312,with [PIONEER 2.0] Physical Therapy FINAL,TwS
101003131,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
102003131,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
103003131,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
104003131,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
105003131,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
106003131,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
107003131,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
108003131,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
109003131,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
110003131,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
111003131,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
112003131,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
113003131,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
114003131,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
115003131,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
116003131,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
117003131,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
118003131,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,313,with [PIONEER 2.0] Metastasis stage M1a FINAL,TwS
101003141,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
102003141,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
103003141,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
104003141,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
105003141,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
106003141,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
107003141,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
108003141,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
109003141,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
110003141,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
111003141,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
112003141,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
113003141,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
114003141,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
115003141,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
116003141,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
117003141,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
118003141,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,314,with [PIONEER 2.0] Metastasis stage M1b FINAL,TwS
101003151,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
102003151,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
103003151,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
104003151,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
105003151,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
106003151,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
107003151,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
108003151,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
109003151,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
110003151,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
111003151,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
112003151,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
113003151,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
114003151,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
115003151,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
116003151,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
117003151,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
118003151,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,315,with [PIONEER 2.0]Â Strata Cohort S26 Metastasis stage M1c,TwS
101003161,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
102003161,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
103003161,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
104003161,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
105003161,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
106003161,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
107003161,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
108003161,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
109003161,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
110003161,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
111003161,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
112003161,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
113003161,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
114003161,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
115003161,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
116003161,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
117003161,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
118003161,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,316,"with [PIONEER 2.0] N1, M0Mx, any T FINAL",TwS
101003171,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
102003171,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
103003171,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
104003171,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
105003171,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
106003171,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
107003171,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
108003171,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
109003171,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
110003171,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
111003171,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
112003171,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
113003171,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
114003171,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
115003171,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
116003171,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
117003171,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
118003171,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,317,with [PIONEER 2.0] Metastasis recurrent RT-FINAL,TwS
101003181,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
102003181,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
103003181,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
104003181,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
105003181,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
106003181,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
107003181,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
108003181,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
109003181,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
110003181,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
111003181,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
112003181,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
113003181,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
114003181,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
115003181,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
116003181,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
117003181,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
118003181,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,318,with [PIONEER 2.0] Metastasis recurrent RP-FINAL,TwS
101003191,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
102003191,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
103003191,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
104003191,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
105003191,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
106003191,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
107003191,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
108003191,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
109003191,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
110003191,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
111003191,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
112003191,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
113003191,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
114003191,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
115003191,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
116003191,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
117003191,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
118003191,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,319,with [PIONEER 2.0] CT scan of whole body around Dx,TwS
101003201,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
102003201,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
103003201,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
104003201,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
105003201,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
106003201,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
107003201,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
108003201,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
109003201,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
110003201,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
111003201,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
112003201,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
113003201,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
114003201,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
115003201,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
116003201,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
117003201,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
118003201,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,320,with [PIONEER 2.0] CT scan of whole body around metastasis,TwS
101003211,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
102003211,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
103003211,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
104003211,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
105003211,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
106003211,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
107003211,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
108003211,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
109003211,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
110003211,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
111003211,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
112003211,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
113003211,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
114003211,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
115003211,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
116003211,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
117003211,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
118003211,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,321,with [PIONEER 2.0] PSA above 20 at Dx FINAL,TwS
101003221,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
102003221,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
103003221,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
104003221,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
105003221,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
106003221,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
107003221,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
108003221,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
109003221,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
110003221,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
111003221,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
112003221,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
113003221,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
114003221,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
115003221,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
116003221,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
117003221,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
118003221,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,322,with [PIONEER 2.0] PSA below 10 at Dx FINAL,TwS
101003231,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
102003231,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
103003231,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
104003231,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
105003231,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
106003231,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
107003231,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
108003231,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
109003231,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
110003231,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
111003231,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
112003231,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
113003231,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
114003231,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
115003231,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
116003231,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
117003231,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
118003231,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,323,with [PIONEER 2.0] PSA 10-20 at Dx FINAL,TwS
101003241,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
102003241,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
103003241,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
104003241,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
105003241,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
106003241,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
107003241,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
108003241,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
109003241,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
110003241,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
111003241,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
112003241,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
113003241,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
114003241,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
115003241,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
116003241,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
117003241,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
118003241,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,324,with [PIONEER 2.0] Gleason Grade 1 at Dx FINAL,TwS
101003251,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
102003251,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
103003251,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
104003251,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
105003251,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
106003251,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
107003251,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
108003251,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
109003251,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
110003251,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
111003251,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
112003251,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
113003251,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
114003251,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
115003251,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
116003251,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
117003251,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
118003251,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,325,with [PIONEER V2.0] Earliest Gleason Grade 2 - 3,TwS
101003261,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
102003261,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
103003261,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
104003261,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
105003261,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
106003261,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
107003261,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
108003261,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
109003261,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
110003261,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
111003261,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
112003261,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
113003261,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
114003261,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
115003261,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
116003261,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
117003261,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
118003261,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,326,with [PIONEER V2.0] Earliest Gleason Grade 4,TwS
101003271,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
102003271,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
103003271,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
104003271,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
105003271,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
106003271,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
107003271,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
108003271,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
109003271,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
110003271,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
111003271,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
112003271,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
113003271,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
114003271,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
115003271,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
116003271,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
117003271,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
118003271,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,327,with [PIONEER V2.0] Earliest Gleason Grade 5,TwS
101003281,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,328,with [PIONEER S1] High-Risk,TwS
102003281,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,328,with [PIONEER S1] High-Risk,TwS
103003281,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,328,with [PIONEER S1] High-Risk,TwS
104003281,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,328,with [PIONEER S1] High-Risk,TwS
105003281,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,328,with [PIONEER S1] High-Risk,TwS
106003281,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,328,with [PIONEER S1] High-Risk,TwS
107003281,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,328,with [PIONEER S1] High-Risk,TwS
108003281,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,328,with [PIONEER S1] High-Risk,TwS
109003281,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,328,with [PIONEER S1] High-Risk,TwS
110003281,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,328,with [PIONEER S1] High-Risk,TwS
111003281,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,328,with [PIONEER S1] High-Risk,TwS
112003281,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,328,with [PIONEER S1] High-Risk,TwS
113003281,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,328,with [PIONEER S1] High-Risk,TwS
114003281,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,328,with [PIONEER S1] High-Risk,TwS
115003281,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,328,with [PIONEER S1] High-Risk,TwS
116003281,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,328,with [PIONEER S1] High-Risk,TwS
117003281,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,328,with [PIONEER S1] High-Risk,TwS
118003281,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,328,with [PIONEER S1] High-Risk,TwS
101003291,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,329,with [PIONEER S2] Low-Risk,TwS
102003291,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,329,with [PIONEER S2] Low-Risk,TwS
103003291,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,329,with [PIONEER S2] Low-Risk,TwS
104003291,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
105003291,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,329,with [PIONEER S2] Low-Risk,TwS
106003291,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
107003291,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
108003291,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
109003291,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
110003291,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
111003291,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,329,with [PIONEER S2] Low-Risk,TwS
112003291,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,329,with [PIONEER S2] Low-Risk,TwS
113003291,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,329,with [PIONEER S2] Low-Risk,TwS
114003291,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,329,with [PIONEER S2] Low-Risk,TwS
115003291,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
116003291,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
117003291,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
118003291,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,329,with [PIONEER S2] Low-Risk,TwS
101003301,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
102003301,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
103003301,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
104003301,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
105003301,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
106003301,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
107003301,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
108003301,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
109003301,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
110003301,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
111003301,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
112003301,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
113003301,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
114003301,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
115003301,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
116003301,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
117003301,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
118003301,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,330,with [PIONEER S3] Intermediate-Risk,TwS
101003311,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
102003311,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
103003311,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
104003311,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
105003311,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
106003311,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
107003311,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
108003311,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
109003311,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
110003311,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
111003311,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
112003311,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
113003311,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
114003311,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
115003311,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
116003311,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
117003311,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
118003311,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,331,with [PIONEER 2.0] MRI of prostate FINAL,TwS
101003321,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
102003321,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
103003321,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
104003321,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
105003321,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
106003321,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
107003321,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
108003321,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
109003321,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
110003321,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
111003321,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
112003321,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
113003321,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
114003321,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
115003321,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
116003321,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
117003321,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
118003321,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,332,with [PIONEER 2.0] Bone scan FINAL,TwS
101003331,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
102003331,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
103003331,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
104003331,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
105003331,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
106003331,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
107003331,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
108003331,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
109003331,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
110003331,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
111003331,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
112003331,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
113003331,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
114003331,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
115003331,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
116003331,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
117003331,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
118003331,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,333,with [PIONEER 2.0] CT thorax_abdomen_pelvis OR full body MRI FINAL,TwS
101003341,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
102003341,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
103003341,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
104003341,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
105003341,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
106003341,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
107003341,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
108003341,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
109003341,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
110003341,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
111003341,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
112003341,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
113003341,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
114003341,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
115003341,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
116003341,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
117003341,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
118003341,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,334,with [PIONEER 2.0] PET-CT imaging FINAL,TwS
101003351,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
102003351,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
103003351,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
104003351,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
105003351,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
106003351,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
107003351,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
108003351,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
109003351,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
110003351,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
111003351,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
112003351,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
113003351,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
114003351,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
115003351,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
116003351,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
117003351,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
118003351,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,335,with [PIONEER 2.0] PSA above 20 at mets dx FINAL,TwS
101003361,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
102003361,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
103003361,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
104003361,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
105003361,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
106003361,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
107003361,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
108003361,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
109003361,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
110003361,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
111003361,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
112003361,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
113003361,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
114003361,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
115003361,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
116003361,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
117003361,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
118003361,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,336,with [PIONEER 2.0] PSA below 10 at mets dx FINAL,TwS
101003371,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
102003371,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
103003371,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
104003371,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
105003371,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
106003371,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
107003371,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
108003371,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
109003371,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
110003371,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
111003371,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
112003371,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
113003371,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
114003371,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
115003371,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
116003371,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
117003371,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
118003371,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,337,with [PIONEER 2.0] PSA 10-20 at mets dx FINAL,TwS
101003381,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
102003381,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
103003381,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
104003381,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
105003381,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
106003381,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
107003381,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
108003381,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
109003381,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
110003381,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
111003381,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
112003381,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
113003381,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
114003381,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
115003381,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
116003381,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
117003381,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
118003381,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,338,with [PIONEER 2.0] T1cN0NxM0Mx-FINAL,TwS
101003391,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
102003391,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
103003391,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
104003391,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
105003391,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
106003391,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
107003391,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
108003391,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
109003391,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
110003391,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
111003391,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
112003391,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
113003391,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
114003391,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
115003391,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
116003391,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
117003391,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
118003391,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,339,with [PIONEER 2.0] T2abN0NxM0Mx-FINAL,TwS
101003401,101,[PIONEER 2.0] Target Cohort 1.0_ mHSPC FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
102003401,102,[PIONEER 2.0] Target Cohort 1.1_mHSPC (synchronous) FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
103003401,103,[PIONEER 2.0] Target Cohort 1.2_metachronous mHSPC FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
104003401,104,[PIONEER 2.0] Target Cohort 2.0_mHSPC treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
105003401,105,[PIONEER 2.0] Target Cohort 2.1_mHSPC treated (synchronous) FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
106003401,106,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
107003401,107,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT only treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
108003401,108,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
109003401,109,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+Chemo treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
110003401,110,[PIONEER 2.0] Target Cohort 2.0_mHSPC ADT+ARTA+Chemo treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
111003401,111,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT only treated (synchronous) FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
112003401,112,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA treated (synchronous) FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
113003401,113,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+Chemo treated (synchronous) FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
114003401,114,[PIONEER 2.0] Target Cohort 2.1_mHSPC ADT+ARTA+Chemo treated (synchronous) FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
115003401,115,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT only treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
116003401,116,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+Chemo treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
117003401,117,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
118003401,118,[PIONEER 2.0] Target Cohort 2.2_metachronous mHSPC ADT+ARTA+Chemo treated FINAL,340,with [PIONEER 2.0] T2c+N0NxM0Mx-FINAL,TwS
